Why the Finns Do Not Drink but Die and the French Drink but Do Not Die

Return to main article:

A successful public health prevention program requires knowledge of factors that may increase the likelihood of maintaining health or developing a disease. Several different study types can be employed to gain a better understanding of such risk factors. Which study type is most appropriate depends on the question at hand; each study type has its own set of strengths and weaknesses.

Initial explorations of the relation between a suspected risk factor and a disease may include examining their correlations across several countries. For example, plotting estimated alcohol consumption per capita and death rates from coronary heart disease (CHD) against each other reveals that the population of Finland has low alcohol consumption but very high mortality from CHD. Conversely, the French have a high consumption of alcoholic beverages but one of the lowest death rates from CHD. What can we learn from these observations? Such ecological studies suggest that alcohol consumption may reduce the risk of dying from heart disease. But this picture could be distorted by other lifestyle factors correlated with alcohol consumption and also with CHD mortality. The Finns have a high consumption of saturated fat, which is associated with a high risk of heart disease, and the French have a diet rich in vegetable oil and fresh fruits and vegetables, which are associated with a low risk of heart disease—although the French do like their butter, too. So are these other dietary factors, rather than alcohol consumption, truly responsible for the differences in heart disease mortality? If so, they would confound the association between alcohol and CHD mortality. And then there is Japan: the Japanese do not drink much alcohol and they do not die from CHD! This observation confirms that the story is not straightforward and that other factors may play important roles in influencing or confounding the association of interest. A confounder is a third variable that is associated with the risk factor or exposure of interest and is itself a risk factor for the disease. We can think of many factors that fulfill these conditions and can therefore distort the association of interest. Our goal is, therefore, to exclude the influence of confounders. To do this we would need data on the individual level. And we need to be able to measure the potential confounders. We can then eliminate their influence statistically by holding their level constant in so-called regression models (which allow for the simultaneous adjustment of many confounding variables).

Adapted from The Harvard Sampler: Liberal Education for the Twenty-First Century, edited by Jennifer M. Shephard, Stephen M. Kosslyn, and Evelynn M. Hammonds, to be published October 2011 by Harvard University Press. Copyright © 2011 by the President and Fellows of Harvard College. All rights reserved.

From “Medical Detectives,” by Karin B. Michels, associate professor of obstetrics, gynecology, and reproductive health, Harvard Medical School, and associate professor, department of epidemiology, Harvard School of Public Health, who teaches Empirical and Mathematical Reasoning 15 under the same title.

Read more articles by: Karin B. Michels

You might also like

Historic Humor

University Archives to preserve Harvard Lampoon materials

Academia’s Absence from Homelessness

“The lack of dedicated research funding in this area is a major, major problem.”

The Enterprise Research Campus, Part Two

Tishman Speyer signals readiness to pursue approval for second phase of commercial development.  

Most popular

Poise, in Spite of Everything

Nina Skov Jensen ’25, portraitist for collectors and the princess of Denmark. 

Claudine Gay in First Post-Presidency Appearance

At Morning Prayers, speaks of resilience and the unknown

More to explore

Exploring Political Tribalism and American Politics

Mina Cikara explores how political tribalism feeds the American bipartisan divide.

Private Equity in Medicine and the Quality of Care

Hundreds of U.S. hospitals are owned by private equity firms—does monetizing medicine affect the quality of care?

Construction on Commercial Enterprise Research Campus in Allston

Construction on Harvard’s commercial enterprise research campus and new theater in Allston